Some are prohibited, but “peptide” is not one universal sports category

Anti-doping rules classify substances and methods according to their definitions. The applicable list and rules depend on the sport and governing organization. The World Anti-Doping Agency's list is widely used, but professional leagues may operate under separate policies.

The 2026 WADA list includes non-approved substances in section S0 and peptide hormones, growth factors, related substances and mimetics in section S2. BPC-157 is explicitly included under S0. The list also covers some substances by broader class or similar biological effect, so a compound need not always be individually named to fall within a prohibition. WADA 2026 Prohibited List.

Other categories also matter. Section S4 covers hormone and metabolic modulators and includes examples such as MOTS-c and insulins. S0, S2 and S4 are prohibited both in and out of competition; other list categories have different timing or sport-specific rules. These examples are not an exhaustive substance check. WADA 2026 Prohibited List.

Does a prescription make a prohibited substance permitted?

Not automatically. A prescription and a sport exemption are separate matters. An athlete who needs a prohibited treatment may need a therapeutic use exemption under the relevant rules. The exact requirements should be checked with the athlete's anti-doping organization and clinician, rather than assumed from a product description. Sport Integrity Australia: Peptides.

Why the exact name matters

A broad marketing label can obscure the actual ingredient. Product contamination, undeclared substances or ambiguous names can also create risk. An online statement that a product is “legal,” “natural” or “not a steroid” does not answer whether it is prohibited in sport.

Checking only a commercial ingredient list is insufficient if the identity is uncertain. The athlete should establish the exact substance and then consult the appropriate official rules. Under the World Anti-Doping Code, presence or use violations can be established without proving intent or fault, a principle called strict liability. Fault can still affect consequences. An inaccurate product label therefore does not automatically eliminate the athlete’s responsibility. World Anti-Doping Code, Articles 2.1–2.2. This article does not provide an individual clearance to use any product.

Current rules versus future rules

This article is dated November 4, 2026. The 2026 WADA list is the relevant annual list for the remainder of 2026; announced 2027 changes should not be confused with the currently effective version. Rules can also differ between in-competition and out-of-competition use.

Takeaway: Check the exact ingredient against the athlete's governing rules and obtain professional guidance before a decision. A medical prescription, research-use label or absence from a short example list is not proof of permission.

Review flag: Anti-doping review and date verification required at publication and each annual list change.